Kickoff of APA’s “Looking Beyond Series” Explores the Social Determinants of Mental Health
The social determinants of health and mental health were the focus of a recent APA Mental Health Equity Fireside Chat hosted by APA’s Division of Diversity and Health Equity and moderated by Division Chief and Deputy Medical Director Regina James, M.D.
What APA Is Doing for You: Update on Clozapine REMS
- By Saul Levin, M.D., M.P.A., FRCP-E, FRCPsych
In November 2021, the Food and Drug Administration (FDA) instituted a new Clozapine Risk Evaluation and Mitigation Strategy (REMS) to monitor prescribing and dispensing of the drug, which is used to treat schizophrenia. The new REMS led to confusion for manufacturers, pharmacies, prescribers, and patients. Some clinicians stopped prescribing the already underutilized drug, and some pharmacies stopped dispensing it. This chaotic situation led the FDA to stop enforcing certain requirements of the REM for 90 days.
Women’s History Month: Spotlighting the Women Leaders of APA
March is Women’s History Month and we’re highlighting several women currently leading the organization: APA President Vivian Pender, M.D., President-Elect Rebecca W. Brendel, M.D., J.D., and Assembly Speaker Mary Jo Fitz-Gerald, M.D., M.B.A.
APA Members: Remember to Vote by Jan. 31
Because of changes to the election guidelines in effect this year that are designed to even the playing field, APA helped to produce some additional materials about the candidates.
5 APA/SMI Adviser Courses to Help you Support Patient Well-Being in the New Year
Several American Psychiatric Association (APA) courses, offered through SMI Adviser, cover ways to promote well-being among patients, whether though exercise, connecting with others, or positivity.